KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Receivables (2016 - 2025)

CareDx's Receivables history spans 13 years, with the latest figure at $42.6 million for Q4 2025.

  • For Q4 2025, Receivables fell 34.02% year-over-year to $42.6 million; the TTM value through Dec 2025 reached $42.6 million, down 34.02%, while the annual FY2025 figure was $42.6 million, 34.02% down from the prior year.
  • Receivables for Q4 2025 was $42.6 million at CareDx, down from $47.8 million in the prior quarter.
  • Across five years, Receivables topped out at $30.0 billion in Q2 2021 and bottomed at $42.6 million in Q4 2025.
  • The 5-year median for Receivables is $65.0 million (2022), against an average of $3.1 billion.
  • The largest annual shift saw Receivables surged 110556.19% in 2021 before it plummeted 99.77% in 2022.
  • A 5-year view of Receivables shows it stood at $59.8 million in 2021, then grew by 10.96% to $66.3 million in 2022, then decreased by 23.0% to $51.1 million in 2023, then rose by 26.53% to $64.6 million in 2024, then crashed by 34.02% to $42.6 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Receivables are $42.6 million (Q4 2025), $47.8 million (Q3 2025), and $67.4 million (Q2 2025).